Get the Stockscreener App
2.40
0.41%
-0.01
After Hours:
2.40
Edesa Biotech Inc stock is traded at $2.40, with a volume of 4,019.
It is down -0.41% in the last 24 hours and up +10.60% over the past month.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
See More
Previous Close:
$2.41
Open:
$2.4
24h Volume:
4,019
Relative Volume:
0.19
Market Cap:
$16.89M
Revenue:
-
Net Income/Loss:
$-7.72M
P/E Ratio:
-0.9093
EPS:
-2.6394
Net Cash Flow:
$-6.25M
1W Performance:
-5.14%
1M Performance:
+10.60%
6M Performance:
+0.63%
1Y Performance:
-45.58%
1-Day Range:
$2.40
$2.45
1-Week Range:
$2.40
$2.51
52-Week Range:
$1.55
$5.00
Edesa Biotech Inc Stock (EDSA) Company Profile
Name
Edesa Biotech Inc
Sector
Industry
Phone
(905) 475-1234
Address
100 SPY COURT, MARKHAM, ON
Compare EDSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.40 | 17.20M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Stock (EDSA) Latest News
Risk adjusted return profile for Edesa Biotech Inc. analyzed2025 Valuation Update & Reliable Volume Spike Trade Alerts - Newser
is edesa biotech inc. stock ready for a breakoutCEO Change & AI Forecasted Entry/Exit Points - Newser
Will Edesa Biotech Inc. price bounce be sustainableStop Loss & High Accuracy Swing Entry Alerts - Newser
Is Edesa Biotech Inc. trending in predictive chart modelsJuly 2025 Breakouts & Expert-Curated Trade Recommendations - Newser
Published on: 2025-09-12 16:14:20 - Newser
Published on: 2025-09-12 12:54:37 - Newser
Published on: 2025-09-12 12:48:21 - Newser
Edesa Biotech Inc. stock outlook for YEARTrade Volume Summary & Long-Term Growth Plans - Newser
Using portfolio simulators with Edesa Biotech Inc. includedWeekly Profit Analysis & Real-Time Sentiment Analysis - Newser
Edesa Biotech Inc. stock daily chart insights2025 Support & Resistance & Stock Market Timing Techniques - Newser
Is Edesa Biotech Inc. meeting your algorithmic filter criteriaEarnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser
Quantitative breakdown of Edesa Biotech Inc. recent moveWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
What institutional flow reveals about Edesa Biotech Inc.2025 Risk Factors & Long-Term Safe Investment Plans - Newser
Edesa Biotech Inc. recovery potential after sell offEarnings Risk Summary & Real-Time Chart Breakout Alerts - Newser
Is Edesa Biotech Inc. reversing from oversold territoryForecast Cut & Free Technical Pattern Based Buy Signals - Newser
Leading vs lagging indicators on Edesa Biotech Inc. performanceQuarterly Earnings Summary & Verified Swing Trading Watchlist - Newser
Regression analysis insights on Edesa Biotech Inc. performanceJuly 2025 Sentiment & Expert Verified Movement Alerts - Newser
What’s the recovery path for long term holders of Edesa Biotech Inc.July 2025 Macro Moves & Entry and Exit Point Strategies - Newser
Published on: 2025-09-10 02:46:09 - Newser
Understanding Edesa Biotech Inc.’s price movementQuarterly Portfolio Summary & Long-Term Safe Investment Plans - Newser
Custom watchlist performance reports with Edesa Biotech Inc.Trade Analysis Report & Fast Gain Stock Trading Tips - Newser
Can technical indicators confirm Edesa Biotech Inc.’s reversalChart Signals & Real-Time Chart Pattern Alerts - Newser
Visual trend scoring systems applied to Edesa Biotech Inc.Market Activity Report & Target Return Focused Stock Picks - Newser
How to build a custom watchlist for Edesa Biotech Inc.Trade Analysis Report & Expert Approved Momentum Ideas - Newser
Edesa Biotech Launches At-The-Market Offering Program - TipRanks
Intraday pattern recognizer results for Edesa Biotech Inc.2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Edesa Biotech Inc. Recovery Hinges on Volume BreakoutMarket Trend Summary & Verified Trade Idea Suggestions - beatles.ru
Published on: 2025-09-08 15:00:16 - Newser
Quant Tools Rank Edesa Biotech Inc. as High Risk High Reward2025 Volatility Report & Fast Gain Swing Alerts - beatles.ru
Is Edesa Biotech Inc. stock ready for a breakout2025 Volume Leaders & Accurate Technical Buy Alerts - Newser
Edesa Biotech Inc Stock (EDSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):